ECOST
Effectiveness and Costs of ICD Follow-up Schedule with Telecardiology
Laurence Guédon-Moreau, European Heart Journal 2013
Study Design
- Randomized, interventional, multicenter study
- Compares the safety of continuous BIOTRONIK Home Monitoring versus conventional ambulatory follow-up of ICDs
- 433 patients at 43 centers in France
Key Result 1
Remote follow-up with BIOTRONIK Home Monitoring® is as safe as conventional ambulatory follow-up.
![Proportion of Patients](/sites/default/files/styles/site_width/public/migrated_images/bio20672_553x368.jpg?itok=hym9Z24j)
Clinical Relevance
- The ECOST study shows that BIOTRONIK Home Monitoring of ICDs is a safe alternative to in-office follow-ups. It positively impacts patient outcome, specially when it comes to reducing the risk of inappropriate shocks – a very unpleasant experience
- The value of BIOTRONIK Home Monitoring for continuous remote monitoring, through its daily transmissions, is essential for clinics to better manage their patients health condition
Study Objective |
|
---|---|
1° Endpoints |
|
2° Endpoints |
|
Clinical Sites |
|
Sample Size |
|
Inclusion Criteria |
|
Main Exclusion Criteria #1 |
|
Main Exclusion Criteria #2 |
|
Devices |
|
Study Flowchart |
![]() |
Follow-Up |
|
Study Duration |
|
Reference no. |
|
Principal Investigators |
|
Download Section
Related Products
Tachycardia Therapy
BIOTRONIK offers an extensive product portfolio in the area of tachycardia therapy.
![Tachy Teaser](/sites/default/files/styles/site_width/public/migrated_images/bio13441_553x246.jpg?itok=sZ4yHdcv)
![Monitoring Teaser](/sites/default/files/styles/site_width/public/migrated_images/bio14121_553x246.jpg?itok=1Re5iitI)
Cardiac Remote Monitoring
BIOTRONIK offers Home Monitoring for its complete product portfolio.